Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jesse Schold to Kidney Transplantation

This is a "connection" page, showing publications Jesse Schold has written about Kidney Transplantation.

 
Connection Strength
  
 
 
33.477
  
  1. McElroy LM, Schold JD. Moving toward Racial Equity in Preemptive Listing for Kidney Transplant in the United States. Clin J Am Soc Nephrol. 2024 03 01; 19(3):278-279.
    View in: PubMed
    Score: 0.597
  2. Schold JD, Mohan S, Jackson WE, Stites E, Burton JR, Bababekov YJ, Saben JL, Pomposelli JJ, Pomfret EA, Kaplan B. Differential in Kidney Graft Years on the Basis of Solitary Kidney, Simultaneous Liver-Kidney, and Kidney-after-Liver Transplants. Clin J Am Soc Nephrol. 2024 03 01; 19(3):364-373.
    View in: PubMed
    Score: 0.589
  3. Schold JD, Huml AM, Husain SA, Mohan S. Why the National Academies Got it Wrong about Changing Preemptive Listing Priority for Kidney Transplantation. J Am Soc Nephrol. 2023 10 01; 34(10):1615-1617.
    View in: PubMed
    Score: 0.577
  4. Schold JD. The promise and reality of machine-learning models in kidney transplantation. Kidney Int. 2023 05; 103(5):835-836.
    View in: PubMed
    Score: 0.568
  5. Schold JD, Huml AM, Husain SA, Poggio ED, Buchalter RB, Lopez R, Kaplan B, Mohan S. Deceased donor kidneys from higher distressed communities are significantly less likely to be utilized for transplantation. Am J Transplant. 2023 11; 23(11):1723-1732.
    View in: PubMed
    Score: 0.564
  6. Buchalter RB, Huml AM, Poggio ED, Schold JD. Geographic hot spots of kidney transplant candidates wait-listed post-dialysis. Clin Transplant. 2022 12; 36(12):e14821.
    View in: PubMed
    Score: 0.545
  7. Schold JD, Huml AM, Poggio ED, Reese PP, Mohan S. A tool for decision-making in kidney transplant candidates with poor prognosis to receive deceased donor transplantation in the United States. Kidney Int. 2022 09; 102(3):640-651.
    View in: PubMed
    Score: 0.535
  8. Huml AM, Schold JD. A Second Chance at Transplant First: Preemptive Repeat Kidney Transplantation. Kidney360. 2022 01 27; 3(1):11-13.
    View in: PubMed
    Score: 0.520
  9. Schold JD, Nordyke RJ, Wu Z, Corvino F, Wang W, Mohan S. Clinical Events and Renal Function in the First Year Predict Long-Term Kidney Transplant Survival. Kidney360. 2022 04 28; 3(4):714-727.
    View in: PubMed
    Score: 0.520
  10. Mohan S, King KL, Husain SA, Schold JD. COVID-19-Associated Mortality among Kidney Transplant Recipients and Candidates in the United States. Clin J Am Soc Nephrol. 2021 11; 16(11):1695-1703.
    View in: PubMed
    Score: 0.509
  11. Huml AM, Schold JD. Kidney Transplantation and Candidate BMI: Viability Is in the Eye of the Beholder. Am J Kidney Dis. 2021 10; 78(4):484-486.
    View in: PubMed
    Score: 0.497
  12. Schold JD, King KL, Husain SA, Poggio ED, Buccini LD, Mohan S. COVID-19 mortality among kidney transplant candidates is strongly associated with social determinants of health. Am J Transplant. 2021 07; 21(7):2563-2572.
    View in: PubMed
    Score: 0.492
  13. Schold JD, Mohan S. A deeper dive into the impact of multiple-organ transplant policy on kidney transplant candidate prognoses. Am J Transplant. 2021 06; 21(6):2004-2006.
    View in: PubMed
    Score: 0.487
  14. Poggio ED, Augustine JJ, Arrigain S, Brennan DC, Schold JD. Long-term kidney transplant graft survival-Making progress when most needed. Am J Transplant. 2021 08; 21(8):2824-2832.
    View in: PubMed
    Score: 0.487
  15. Schold JD. Shifting transplant center performance evaluations upstream. Am J Transplant. 2021 01; 21(1):7-8.
    View in: PubMed
    Score: 0.477
  16. Schold JD, Augustine JJ, Huml AM, Fatica R, Nurko S, Wee A, Poggio ED. Effects of body mass index on kidney transplant outcomes are significantly modified by patient characteristics. Am J Transplant. 2021 02; 21(2):751-765.
    View in: PubMed
    Score: 0.472
  17. Huml AM, Sedor JR, Poggio E, Patzer RE, Schold JD. An opt-out model for kidney transplant referral: The time has come. Am J Transplant. 2021 01; 21(1):32-36.
    View in: PubMed
    Score: 0.467
  18. Schold JD, Augustine JJ, Huml AM, O'Toole J, Sedor JR, Poggio ED. Modest rates and wide variation in timely access to repeat kidney transplantation in the United States. Am J Transplant. 2020 03; 20(3):769-778.
    View in: PubMed
    Score: 0.447
  19. Schold JD, Patzer RE, Pruett TL, Mohan S. Quality Metrics in Kidney Transplantation: Current Landscape, Trials and Tribulations, Lessons Learned, and a Call for Reform. Am J Kidney Dis. 2019 09; 74(3):382-389.
    View in: PubMed
    Score: 0.430
  20. Schold JD, Arrigain S, Flechner SM, Augustine JJ, Sedor JR, Wee A, Goldfarb DA, Poggio ED. Dramatic secular changes in prognosis for kidney transplant candidates in the United States. Am J Transplant. 2019 02; 19(2):414-424.
    View in: PubMed
    Score: 0.410
  21. Augustine JJ, Arrigain S, Balabhadrapatruni K, Desai N, Schold JD. Significantly Lower Rates of Kidney Transplantation among Candidates Listed with the Veterans Administration: A National and Local Comparison. J Am Soc Nephrol. 2018 10; 29(10):2574-2582.
    View in: PubMed
    Score: 0.407
  22. Schold JD, Poggio ED, Augustine JJ. Gathering Clues to Explain the Stagnation in Living Donor Kidney Transplantation in the United States. Am J Kidney Dis. 2018 05; 71(5):608-610.
    View in: PubMed
    Score: 0.402
  23. Schold JD, Locke JE. Assessing emergency department utilization in the era of population health. Am J Transplant. 2018 04; 18(4):777-778.
    View in: PubMed
    Score: 0.394
  24. Schold JD, Miller CM, Henry ML, Buccini LD, Flechner SM, Goldfarb DA, Poggio ED, Andreoni KA. Evaluation of Flagging Criteria of United States Kidney Transplant Center Performance: How to Best Define Outliers? Transplantation. 2017 06; 101(6):1373-1380.
    View in: PubMed
    Score: 0.377
  25. Schold JD, Buccini LD, Phelan MP, Jay CL, Goldfarb DA, Poggio ED, Sedor JR. Building an Ideal Quality Metric for ESRD Health Care Delivery. Clin J Am Soc Nephrol. 2017 08 07; 12(8):1351-1356.
    View in: PubMed
    Score: 0.376
  26. Schold JD, Reed AI. Developing Financial Incentives for Kidney Transplant Centers: Who Is Minding the Store? Am J Transplant. 2017 02; 17(2):315-317.
    View in: PubMed
    Score: 0.361
  27. Schold JD, Elfadawy N, Buccini LD, Goldfarb DA, Flechner SM, P Phelan M, Poggio ED. Emergency Department Visits after Kidney Transplantation. Clin J Am Soc Nephrol. 2016 Apr 07; 11(4):674-83.
    View in: PubMed
    Score: 0.347
  28. Schold JD, Buccini LD, Poggio ED, Flechner SM, Goldfarb DA. Association of Candidate Removals From the Kidney Transplant Waiting List and Center Performance Oversight. Am J Transplant. 2016 Apr; 16(4):1276-84.
    View in: PubMed
    Score: 0.342
  29. Schold JD. Editorial Comment. Urology. 2016 Jan; 87:92-3.
    View in: PubMed
    Score: 0.339
  30. Schold J, Poggio E, Goldfarb D, Kayler L, Flechner S. Clinical outcomes associated with induction regimens among retransplant kidney recipients in the United States. Transplantation. 2015 Jun; 99(6):1165-71.
    View in: PubMed
    Score: 0.328
  31. Schold JD, Opelz G. Transplantation: The vexing challenges of deceased donor organ allocation. Nat Rev Nephrol. 2015 Aug; 11(8):448-50.
    View in: PubMed
    Score: 0.326
  32. Schold JD, Buccini LD, Rodrigue JR, Mandelbrot D, Goldfarb DA, Flechner SM, Kayler LK, Poggio ED. Critical Factors Associated With Missing Follow-Up Data for Living Kidney Donors in the United States. Am J Transplant. 2015 Sep; 15(9):2394-403.
    View in: PubMed
    Score: 0.326
  33. Schold JD, Nicholas LH. Considering potential benefits and consequences of hospital report cards: what are the next steps? Health Serv Res. 2015 Apr; 50(2):321-9.
    View in: PubMed
    Score: 0.324
  34. Schold JD. For kidney transplant recipients, 70 is the new 50. J Am Geriatr Soc. 2014 Dec; 62(12):2430-2.
    View in: PubMed
    Score: 0.317
  35. Schold JD, Buccini LD, Reese PP, Poggio ED, Goldfarb DA. Effect of dialysis initiation for preemptively listed candidates in the revised kidney allocation policy. Am J Transplant. 2014 Dec; 14(12):2855-60.
    View in: PubMed
    Score: 0.313
  36. Schold JD, Buccini LD, Goldfarb DA, Flechner SM, Poggio ED, Sehgal AR. Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis. Clin J Am Soc Nephrol. 2014 Oct 07; 9(10):1773-80.
    View in: PubMed
    Score: 0.312
  37. Sakhuja A, Stephany B, Deitzer D, Kumar G, Schold JD. Trends of pulmonary embolism before and after kidney transplantation in black versus white patients. Transplant Proc. 2014 Jun; 46(5):1353-61.
    View in: PubMed
    Score: 0.306
  38. Schold JD, Reese PP. Simulating the new kidney allocation policy in the United States: modest gains and many unknowns. J Am Soc Nephrol. 2014 Aug; 25(8):1617-9.
    View in: PubMed
    Score: 0.305
  39. Heaphy EL, Poggio ED, Flechner SM, Goldfarb DA, Askar M, Fatica R, Srinivas TR, Schold JD. Risk factors for retransplant kidney recipients: relisting and outcomes from patients' primary transplant. Am J Transplant. 2014 Jun; 14(6):1356-67.
    View in: PubMed
    Score: 0.303
  40. Shoskes DA, Kerr H, Askar M, Goldfarb DA, Schold J. Low testosterone at time of transplantation is independently associated with poor patient and graft survival in male renal transplant recipients. J Urol. 2014 Oct; 192(4):1168-71.
    View in: PubMed
    Score: 0.303
  41. Schold JD, Goldfarb DA, Buccini LD, Rodrigue JR, Mandelbrot D, Heaphy EL, Fatica RA, Poggio ED. Hospitalizations following living donor nephrectomy in the United States. Clin J Am Soc Nephrol. 2014 Feb; 9(2):355-65.
    View in: PubMed
    Score: 0.299
  42. Buccini LD, Schold JD. Considerations of reliability and validity of transplant center report cards. Am J Transplant. 2014 Jan; 14(1):239-40.
    View in: PubMed
    Score: 0.296
  43. Schold JD, Goldfarb DA, Buccini LD, Rodrigue JR, Mandelbrot DA, Heaphy EL, Fatica RA, Poggio ED. Comorbidity burden and perioperative complications for living kidney donors in the United States. Clin J Am Soc Nephrol. 2013 Oct; 8(10):1773-82.
    View in: PubMed
    Score: 0.292
  44. Schold JD, Heaphy EL, Buccini LD, Poggio ED, Srinivas TR, Goldfarb DA, Flechner SM, Rodrigue JR, Thornton JD, Sehgal AR. Prominent impact of community risk factors on kidney transplant candidate processes and outcomes. Am J Transplant. 2013 Sep; 13(9):2374-83.
    View in: PubMed
    Score: 0.290
  45. Schold JD. The burden of proof in the design of early phase clinical trials. Am J Transplant. 2013 Jul; 13(7):1631-2.
    View in: PubMed
    Score: 0.287
  46. Schold JD, Buccini LD, Heaphy EL, Goldfarb DA, Sehgal AR, Fung J, Poggio ED, Kattan MW. The prognostic value of kidney transplant center report cards. Am J Transplant. 2013 Jul; 13(7):1703-12.
    View in: PubMed
    Score: 0.285
  47. Braun WE, Protiva DA, Schold JD. Decreased total CD19? B lymphocytes and the occurrence of monoclonal proteins are frequent in ultra-long (30 to 44-year) renal transplant recipients: implications for allograft and patient survival. Transplant Proc. 2013 May; 45(4):1466-8.
    View in: PubMed
    Score: 0.284
  48. Heaphy ELG, Goldfarb DA, Poggio ED, Buccini LD, Flechner SM, Schold JD. The impact of deceased donor kidney risk significantly varies by recipient characteristics. Am J Transplant. 2013 Apr; 13(4):1001-1011.
    View in: PubMed
    Score: 0.280
  49. Schold JD, Buccini LD, Srinivas TR, Srinivas RT, Poggio ED, Flechner SM, Soria C, Segev DL, Fung J, Goldfarb DA. The association of center performance evaluations and kidney transplant volume in the United States. Am J Transplant. 2013 Jan; 13(1):67-75.
    View in: PubMed
    Score: 0.278
  50. Schold JD, Buccini LD, Kattan MW, Goldfarb DA, Flechner SM, Srinivas TR, Poggio ED, Fatica R, Kayler LK, Sehgal AR. The association of community health indicators with outcomes for kidney transplant recipients in the United States. Arch Surg. 2012 Jun; 147(6):520-6.
    View in: PubMed
    Score: 0.266
  51. Schold JD, Segev DL. Increasing the pool of deceased donor organs for kidney transplantation. Nat Rev Nephrol. 2012 Mar 27; 8(6):325-31.
    View in: PubMed
    Score: 0.263
  52. Fissell RB, Srinivas T, Fatica R, Nally J, Navaneethan S, Poggio E, Goldfarb D, Schold J. Preemptive renal transplant candidate survival, access to care, and renal function at listing. Nephrol Dial Transplant. 2012 Aug; 27(8):3321-9.
    View in: PubMed
    Score: 0.263
  53. Kayler LK, Srinivas TR, Schold JD. Influence of CIT-induced DGF on kidney transplant outcomes. Am J Transplant. 2011 Dec; 11(12):2657-64.
    View in: PubMed
    Score: 0.256
  54. Kayler LK, Magliocca J, Zendejas I, Srinivas TR, Schold JD. Impact of cold ischemia time on graft survival among ECD transplant recipients: a paired kidney analysis. Am J Transplant. 2011 Dec; 11(12):2647-56.
    View in: PubMed
    Score: 0.253
  55. Schold JD, Gregg JA, Harman JS, Hall AG, Patton PR, Meier-Kriesche HU. Barriers to evaluation and wait listing for kidney transplantation. Clin J Am Soc Nephrol. 2011 Jul; 6(7):1760-7.
    View in: PubMed
    Score: 0.248
  56. Braun WE, Schold JD. Transplantation: strength in numbers-predicting long-term transplant outcomes. Nat Rev Nephrol. 2011 Mar; 7(3):135-6.
    View in: PubMed
    Score: 0.243
  57. Kayler LK, Sokolich J, Magliocca J, Schold JD. Import kidney transplants from nonmandatory share deceased donors: characteristics, distribution and outcomes. Am J Transplant. 2011 Jan; 11(1):77-85.
    View in: PubMed
    Score: 0.242
  58. Srinivas TR, Flechner SM, Poggio ED, Askar M, Goldfarb DA, Navaneethan SD, Schold JD. Glomerular filtration rate slopes have significantly improved among renal transplants in the United States. Transplantation. 2010 Dec 27; 90(12):1499-505.
    View in: PubMed
    Score: 0.241
  59. Schold JD, Hall YN. Enhancing the expanded criteria donor policy as an intervention to improve kidney allocation: is it actually a 'net-zero' model? Am J Transplant. 2010 Dec; 10(12):2582-5.
    View in: PubMed
    Score: 0.240
  60. Schold JD, Srinivas TR, Braun WE, Shoskes DA, Nurko S, Poggio ED. The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age. Clin Transplant. 2011 Sep-Oct; 25(5):721-30.
    View in: PubMed
    Score: 0.238
  61. Schold JD, Srinivas TR, Poggio ED, Stephany BR, Flechner SM, Goldfarb DA, Kattan MW. Hidden selection bias deriving from donor organ characteristics does not affect performance evaluations of kidney transplant centers. Med Care. 2010 Oct; 48(10):907-14.
    View in: PubMed
    Score: 0.237
  62. Srinivas TR, Stephany BR, Budev M, Mason DP, Starling RC, Miller C, Goldfarb DA, Flechner SM, Poggio ED, Schold JD. An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation. Clin J Am Soc Nephrol. 2010 Oct; 5(10):1881-6.
    View in: PubMed
    Score: 0.236
  63. Schold JD, Sehgal AR, Srinivas TR, Poggio ED, Navaneethan SD, Kaplan B. Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant. 2010 Sep; 10(9):2008-16.
    View in: PubMed
    Score: 0.234
  64. Schold JD, Kaplan B. The elephant in the room: failings of current clinical endpoints in kidney transplantation. Am J Transplant. 2010 May; 10(5):1163-6.
    View in: PubMed
    Score: 0.231
  65. Kayler LK, Magliocca J, Kim RD, Howard R, Schold JD. Single kidney transplantation from young pediatric donors in the United States. Am J Transplant. 2009 Dec; 9(12):2745-51.
    View in: PubMed
    Score: 0.224
  66. Schold JD, Santos A, Rehman S, Magliocca J, Meier-Kriesche HU. The success of continued steroid avoidance after kidney transplantation in the US. Am J Transplant. 2009 Dec; 9(12):2768-76.
    View in: PubMed
    Score: 0.222
  67. Schold JD, Meier-Kriesche HU. Comparable barriers to access to kidney transplantation across national lines. Transplantation. 2009 Jul 15; 88(1):21-2.
    View in: PubMed
    Score: 0.218
  68. Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation. 2009 Jul 15; 88(1):23-9.
    View in: PubMed
    Score: 0.218
  69. Schold J, Srinivas TR, Sehgal AR, Meier-Kriesche HU. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol. 2009 Jul; 4(7):1239-45.
    View in: PubMed
    Score: 0.217
  70. Kaplan B, Schold J. Transplantation: neural networks for predicting graft survival. Nat Rev Nephrol. 2009 Apr; 5(4):190-2.
    View in: PubMed
    Score: 0.214
  71. Schold JD, Rehman S, Kayle LK, Kayler LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009 Jun; 22(6):626-34.
    View in: PubMed
    Score: 0.212
  72. Schold JD, Harman JS, Chumbler NR, Duncan RP, Meier-Kriesche HU. The pivotal impact of center characteristics on survival of candidates listed for deceased donor kidney transplantation. Med Care. 2009 Feb; 47(2):146-53.
    View in: PubMed
    Score: 0.212
  73. Kayler LK, Garzon P, Magliocca J, Fujita S, Kim RD, Hemming AW, Howard R, Schold JD. Outcomes and utilization of kidneys from deceased donors with acute kidney injury. Am J Transplant. 2009 Feb; 9(2):367-73.
    View in: PubMed
    Score: 0.212
  74. Kaplan B, Schold JD. The practical utility of an economic analysis of calcineurin withdrawal following renal transplantation. J Am Soc Nephrol. 2008 Sep; 19(9):1627-8.
    View in: PubMed
    Score: 0.205
  75. Schold JD, Srinivas TR, Howard RJ, Jamieson IR, Meier-Kriesche HU. The association of candidate mortality rates with kidney transplant outcomes and center performance evaluations. Transplantation. 2008 Jan 15; 85(1):1-6.
    View in: PubMed
    Score: 0.197
  76. Schold JD, Meier-Kriesche HU, Duncan RP, Reed AI. Deceased donor kidney and liver transplantation to nonresident aliens in the United States. Transplantation. 2007 Dec 27; 84(12):1548-56.
    View in: PubMed
    Score: 0.196
  77. Schold JD, Srinivas TR, Kayler LK, Meier-Kriesche HU. The overlapping risk profile between dialysis patients listed and not listed for renal transplantation. Am J Transplant. 2008 Jan; 8(1):58-68.
    View in: PubMed
    Score: 0.194
  78. Schold JD, Srinivas TR, Guerra G, Reed AI, Johnson RJ, Weiner ID, Oberbauer R, Harman JS, Hemming AW, Meier-Kriesche HU. A "weight-listing" paradox for candidates of renal transplantation? Am J Transplant. 2007 Mar; 7(3):550-9.
    View in: PubMed
    Score: 0.182
  79. Schold JD, Meier-Kriesche HU. Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol. 2006 May; 1(3):532-8.
    View in: PubMed
    Score: 0.172
  80. Meier-Kriesche HU, Schold JD. The impact of pretransplant dialysis on outcomes in renal transplantation. Semin Dial. 2005 Nov-Dec; 18(6):499-504.
    View in: PubMed
    Score: 0.169
  81. Schold JD, Kaplan B, Chumbler NR, Howard RJ, Srinivas TR, Ma L, Meier-Kriesche HU. Access to quality: evaluation of the allocation of deceased donor kidneys for transplantation. J Am Soc Nephrol. 2005 Oct; 16(10):3121-7.
    View in: PubMed
    Score: 0.167
  82. Schold JD, Kaplan B, Howard RJ, Reed AI, Foley DP, Meier-Kriesche HU. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. Am J Transplant. 2005 Jul; 5(7):1681-8.
    View in: PubMed
    Score: 0.165
  83. Schold JD, Kaplan B, Baliga RS, Meier-Kriesche HU. The broad spectrum of quality in deceased donor kidneys. Am J Transplant. 2005 Apr; 5(4 Pt 1):757-65.
    View in: PubMed
    Score: 0.162
  84. Cholin LK, Ramos EF, Yahr J, Schold JD, Poggio ED, Delvalle CL, Huml AM. Psychosocial characteristics of potential and actual living kidney donors. BMC Nephrol. 2024 Jan 24; 25(1):31.
    View in: PubMed
    Score: 0.149
  85. Augustine JJ, Liaqat A, Arrigain S, Schold JD, Poggio ED. Performance of estimated glomerular filtration rate equations in Black living kidney donor candidates. Clin Transplant. 2024 01; 38(1):e15198.
    View in: PubMed
    Score: 0.147
  86. Husain SA, Yu ME, King KL, Adler JT, Schold JD, Mohan S. Disparities in Kidney Transplant Waitlisting Among Young Patients Without Medical Comorbidities. JAMA Intern Med. 2023 11 01; 183(11):1238-1246.
    View in: PubMed
    Score: 0.147
  87. Cooper M, Wiseman AC, Doshi MD, Hall IE, Parsons RF, Pastan S, Reddy KS, Schold JD, Mohan S, Hippen BE. Understanding Delayed Graft Function to Improve Organ Utilization and Patient Outcomes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2024 03; 83(3):360-369.
    View in: PubMed
    Score: 0.146
  88. Yu M, King KL, Husain SA, Huml AM, Patzer RE, Schold JD, Mohan S. Discrepant Outcomes between National Kidney Transplant Data Registries in the United States. J Am Soc Nephrol. 2023 11 01; 34(11):1863-1874.
    View in: PubMed
    Score: 0.145
  89. Davis RA, Branagan T, Schneck CD, Schold JD, Thant T, Kaplan B. Lithium and the living kidney donor: Science or stigma? Am J Transplant. 2023 09; 23(9):1300-1306.
    View in: PubMed
    Score: 0.143
  90. Malamon JS, Jackson WE, Saben JL, Conzen K, Schold JD, Pomposelli JJ, Pomfret EA, Kaplan B. A model for calculating the long-term estimated post-transplant survival of deceased donor liver transplant patients. EBioMedicine. 2023 Apr; 90:104505.
    View in: PubMed
    Score: 0.140
  91. Cholin LK, Schold JD, Arrigain S, Poggio ED, Sedor JR, O'Toole JF, Augustine JJ, Wee AC, Huml AM. Characteristics of Potential and Actual Living Kidney Donors: A Single-center Experience. Transplantation. 2023 04 01; 107(4):941-951.
    View in: PubMed
    Score: 0.138
  92. Koval CE, Eltemamy M, Poggio ED, Schold JD, Wee AC. Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience. Am J Transplant. 2022 12; 22(12):2903-2911.
    View in: PubMed
    Score: 0.137
  93. King KL, Husain SA, Cohen DJ, Schold JD, Mohan S. The role of bypass filters in deceased donor kidney allocation in the United States. Am J Transplant. 2022 06; 22(6):1593-1602.
    View in: PubMed
    Score: 0.131
  94. King KL, Husain SA, Perotte A, Adler JT, Schold JD, Mohan S. Deceased donor kidneys allocated out of sequence by organ procurement organizations. Am J Transplant. 2022 05; 22(5):1372-1381.
    View in: PubMed
    Score: 0.130
  95. Gill JS, Schold J, Kaplan B. Understanding Risks and Our Responsibility to Living Donors. J Am Soc Nephrol. 2021 11; 32(11):2691-2693.
    View in: PubMed
    Score: 0.128
  96. Mayne TJ, Nordyke RJ, Schold JD, Weir MR, Mohan S. Defining a minimal clinically meaningful difference in 12-month estimated glomerular filtration rate for clinical trials in deceased donor kidney transplantation. Clin Transplant. 2021 07; 35(7):e14326.
    View in: PubMed
    Score: 0.124
  97. Husain SA, King KL, Sanichar N, Crew RJ, Schold JD, Mohan S. Association Between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant. JAMA Netw Open. 2021 04 01; 4(4):e215718.
    View in: PubMed
    Score: 0.123
  98. Chen DP, Zaky ZS, Schold JD, Herlitz LC, El-Rifai R, Drawz PE, Bruggeman LA, Barisoni L, Hogan SL, Hu Y, O'Toole JF, Poggio ED, Sedor JR. Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation. Clin Transplant. 2021 04; 35(4):e14234.
    View in: PubMed
    Score: 0.122
  99. Augustine JJ, Arrigain S, Mandelbrot DA, Schold JD, Poggio ED. Factors Associated With Residual Kidney Function and Proteinuria After Living Kidney Donation in the United States. Transplantation. 2021 02 01; 105(2):372-381.
    View in: PubMed
    Score: 0.122
  100. Braun WE, Herlitz L, Li J, Schold J, Poggio E, Stephany B, Fatica R, Nally J, Brown K, Fairchild R, Baldwin W, Goldfarb D, Kiser W, Augustine J, Avery R, Tomford JW, Nakamoto S. Continuous function of 80 primary renal allografts for 30-47 years with maintenance prednisone and azathioprine/mycophenolate mofetil therapy: A clinical mosaic of long-term successes. Clin Transplant. 2021 01; 35(1):e14131.
    View in: PubMed
    Score: 0.120
  101. King KL, Husain SA, Schold JD, Patzer RE, Reese PP, Jin Z, Ratner LE, Cohen DJ, Pastan SO, Mohan S. Major Variation across Local Transplant Centers in Probability of Kidney Transplant for Wait-Listed Patients. J Am Soc Nephrol. 2020 12; 31(12):2900-2911.
    View in: PubMed
    Score: 0.119
  102. Fleishman A, Khwaja K, Schold JD, Comer CD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Pavlakis M, Mandelbrot DA, Rodrigue JR. Pain expectancy, prevalence, severity, and patterns following donor nephrectomy: Findings from the KDOC Study. Am J Transplant. 2020 09; 20(9):2522-2529.
    View in: PubMed
    Score: 0.115
  103. Rodrigue JR, Fleishman A, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz DA, Jones J, Kaplan B, Pavlakis M, Mandelbrot DA. Patterns and predictors of fatigue following living donor nephrectomy: Findings from the KDOC Study. Am J Transplant. 2020 01; 20(1):181-189.
    View in: PubMed
    Score: 0.109
  104. Rodrigue JR, Fleishman A, Sokas CM, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Pavlakis M, Mandelbrot DA. Rates of Living Kidney Donor Follow-up: Findings From the KDOC Study. Transplantation. 2019 07; 103(7):e209-e210.
    View in: PubMed
    Score: 0.109
  105. Armanyous S, Ohashi Y, Lioudis M, Schold JD, Thomas G, Poggio ED, Augustine JJ. Diagnostic Performance of Blood Pressure Measurement Modalities in Living Kidney Donor Candidates. Clin J Am Soc Nephrol. 2019 05 07; 14(5):738-746.
    View in: PubMed
    Score: 0.107
  106. Cooper M, Formica R, Friedewald J, Hirose R, O'Connor K, Mohan S, Schold J, Axelrod D, Pastan S. Report of National Kidney Foundation Consensus Conference to Decrease Kidney Discards. Clin Transplant. 2019 01; 33(1):e13419.
    View in: PubMed
    Score: 0.104
  107. Husain SA, Brennan C, Michelson A, Tsapepas D, Patzer RE, Schold JD, Mohan S. Patients prioritize waitlist over posttransplant outcomes when evaluating kidney transplant centers. Am J Transplant. 2018 11; 18(11):2781-2790.
    View in: PubMed
    Score: 0.102
  108. Schold JD, Flechner SM, Poggio ED, Augustine JJ, Goldfarb DA, Sedor JR, Buccini LD. Residential Area Life Expectancy: Association With Outcomes and Processes of Care for Patients With ESRD in the United States. Am J Kidney Dis. 2018 07; 72(1):19-29.
    View in: PubMed
    Score: 0.099
  109. Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA. Mood, body image, fear of kidney failure, life satisfaction, and decisional stability following living kidney donation: Findings from the KDOC study. Am J Transplant. 2018 06; 18(6):1397-1407.
    View in: PubMed
    Score: 0.098
  110. O'Connell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE. Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction. Transplantation. 2017 07; 101(7):1527-1534.
    View in: PubMed
    Score: 0.095
  111. Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold JD, Reese PP. Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation. J Am Soc Nephrol. 2017 Jul; 28(7):2188-2200.
    View in: PubMed
    Score: 0.093
  112. Newell KA, Formica RN, Gill JS, Schold JD, Allan JS, Covington SH, Wiseman AC, Chandraker A. Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference. Am J Transplant. 2017 04; 17(4):901-911.
    View in: PubMed
    Score: 0.092
  113. Lentine KL, Lam NN, Schnitzler MA, Hess GP, Kasiske BL, Xiao H, Axelrod D, Garg AX, Schold JD, Randall H, Dzebisashvili N, Brennan DC, Segev DL. Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation. Am J Transplant. 2017 03; 17(3):744-753.
    View in: PubMed
    Score: 0.090
  114. Sakhuja A, Wright RS, Schold JD, McCarthy JT, Williams AW, Amer H, Albright RC. National Impact of Maintenance Dialysis or Renal Transplantation on Outcomes Following ST Elevation Myocardial Infarction. Am J Nephrol. 2016; 44(5):329-338.
    View in: PubMed
    Score: 0.090
  115. Rodrigue JR, Schold JD, Mandelbrot DA, Taber DJ, Phan V, Baliga PK. Concern for Lost Income Following Donation Deters Some Patients From Talking to Potential Living Donors. Prog Transplant. 2016 Dec; 26(4):292-298.
    View in: PubMed
    Score: 0.089
  116. Snyder JJ, Salkowski N, Wey A, Israni AK, Schold JD, Segev DL, Kasiske BL. Effects of High-Risk Kidneys on Scientific Registry of Transplant Recipients Program Quality Reports. Am J Transplant. 2016 09; 16(9):2646-53.
    View in: PubMed
    Score: 0.087
  117. Lentine KL, Lam NN, Axelrod D, Schnitzler MA, Garg AX, Xiao H, Dzebisashvili N, Schold JD, Brennan DC, Randall H, King EA, Segev DL. Perioperative Complications After Living Kidney Donation: A National Study. Am J Transplant. 2016 06; 16(6):1848-57.
    View in: PubMed
    Score: 0.087
  118. Schold JD, Kaplan B. Living Kidney Donor Profile Index: Utility and Limitations. Am J Transplant. 2016 07; 16(7):1951-2.
    View in: PubMed
    Score: 0.086
  119. Bagga HS, Lin S, Williams A, Schold J, Chertack N, Goldfarb D, Wood H. Trends in Renal Transplantation Rates in Patients with Congenital Urinary Tract Disorders. J Urol. 2016 Apr; 195(4 Pt 2):1257-62.
    View in: PubMed
    Score: 0.086
  120. Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA. Direct and Indirect Costs Following Living Kidney Donation: Findings From the KDOC Study. Am J Transplant. 2016 Mar; 16(3):869-76.
    View in: PubMed
    Score: 0.086
  121. Sakhuja A, Naik A, Amer H, Cibrik D, Eikstadt R, Schold JD, Stegall MD. Underutilization of Timely Kidney Transplants in Those With Living Donors. Am J Transplant. 2016 Mar; 16(3):1007-14.
    View in: PubMed
    Score: 0.086
  122. Tushla L, Rudow DL, Milton J, Rodrigue JR, Schold JD, Hays R. Living-Donor Kidney Transplantation: Reducing Financial Barriers to Live Kidney Donation--Recommendations from a Consensus Conference. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1696-702.
    View in: PubMed
    Score: 0.082
  123. Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA. Predonation Direct and Indirect Costs Incurred by Adults Who Donated a Kidney: Findings From the KDOC Study. Am J Transplant. 2015 Sep; 15(9):2387-93.
    View in: PubMed
    Score: 0.082
  124. LaPointe Rudow D, Hays R, Baliga P, Cohen DJ, Cooper M, Danovitch GM, Dew MA, Gordon EJ, Mandelbrot DA, McGuire S, Milton J, Moore DR, Morgievich M, Schold JD, Segev DL, Serur D, Steiner RW, Tan JC, Waterman AD, Zavala EY, Rodrigue JR. Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. Am J Transplant. 2015 Apr; 15(4):914-22.
    View in: PubMed
    Score: 0.080
  125. Rodrigue JR, Paek MJ, Egbuna O, Waterman AD, Schold JD, Pavlakis M, Mandelbrot DA. Readiness of wait-listed black patients to pursue live donor kidney transplant. Prog Transplant. 2014 Dec; 24(4):355-61.
    View in: PubMed
    Score: 0.079
  126. Rodrigue JR, Paek MJ, Egbuna O, Waterman AD, Schold JD, Pavlakis M, Mandelbrot DA. Making house calls increases living donor inquiries and evaluations for blacks on the kidney transplant waiting list. Transplantation. 2014 Nov 15; 98(9):979-86.
    View in: PubMed
    Score: 0.079
  127. Kayler LK, Wen X, Zacharai M, Casey M, Schold J, Magliocca J. Response: Old-to-old pancreas transplantation, what's old in the USA may be young in Europe. Transpl Int. 2014 Apr; 27(4):e33.
    View in: PubMed
    Score: 0.075
  128. Elfadawy N, Flechner SM, Schold JD, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation. Clin J Am Soc Nephrol. 2014 Mar; 9(3):553-61.
    View in: PubMed
    Score: 0.074
  129. Elfadawy N, Flechner SM, Liu X, Schold J, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation. Transplantation. 2013 Dec 27; 96(12):1097-103.
    View in: PubMed
    Score: 0.074
  130. Rodrigue JR, Schold JD, Mandelbrot DA. The decline in living kidney donation in the United States: random variation or cause for concern? Transplantation. 2013 Nov 15; 96(9):767-73.
    View in: PubMed
    Score: 0.074
  131. Zachariah M, Gregg A, Schold J, Magliocca J, Kayler LK. Alemtuzumab induction in simultaneous pancreas and kidney transplantation. Clin Transplant. 2013 Sep-Oct; 27(5):693-700.
    View in: PubMed
    Score: 0.072
  132. Ohashi Y, Thomas G, Nurko S, Stephany B, Fatica R, Chiesa A, Rule AD, Srinivas T, Schold JD, Navaneethan SD, Poggio ED. Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant. 2013 Sep; 13(9):2342-51.
    View in: PubMed
    Score: 0.072
  133. Kayler LK, Wen X, Zachariah M, Casey M, Schold J, Magliocca J. Outcomes and survival analysis of old-to-old simultaneous pancreas and kidney transplantation. Transpl Int. 2013 Oct; 26(10):963-72.
    View in: PubMed
    Score: 0.072
  134. Elfadawy N, Flechner SM, Liu X, Schold J, Tian D, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation. Transpl Int. 2013 Aug; 26(8):822-32.
    View in: PubMed
    Score: 0.072
  135. Grams ME, Massie AB, Schold JD, Chen BP, Segev DL. Trends in the inactive kidney transplant waitlist and implications for candidate survival. Am J Transplant. 2013 Apr; 13(4):1012-1018.
    View in: PubMed
    Score: 0.070
  136. Askar M, Schold JD, Eghtesad B, Flechner SM, Kaplan B, Klingman L, Zein NN, Fung J, Srinivas TR. Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation. 2011 Jun 15; 91(11):1286-92.
    View in: PubMed
    Score: 0.062
  137. Claes K, Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. Nephrol Dial Transplant. 2012 Feb; 27(2):850-7.
    View in: PubMed
    Score: 0.062
  138. Segev DL, Massie AB, Schold JD, Kaplan B. If you're not fit, you mustn't quit: observational studies and weighing the evidence. Am J Transplant. 2011 Apr; 11(4):652-3.
    View in: PubMed
    Score: 0.061
  139. Kayler LK, Schold JD, Magliocca JF. Response: DonorNet and the potential effects on organ utilization. Am J Transplant. 2010 Oct; 10(10):2376; author reply 2377.
    View in: PubMed
    Score: 0.059
  140. Guerra G, Indahyung R, Bucci CM, Schold JD, Magliocca JF, Meier-Kriesche HU. Elevated incidence of posttransplant erythrocytosis after simultaneous pancreas kidney transplantation. Am J Transplant. 2010 Apr; 10(4):938-942.
    View in: PubMed
    Score: 0.057
  141. Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study. Clin J Am Soc Nephrol. 2009 Oct; 4(10):1655-60.
    View in: PubMed
    Score: 0.055
  142. Scornik JC, Schold JD, Bucci M, Meier-Kriesche HU. Effects of blood transfusions given after renal transplantation. Transplantation. 2009 May 15; 87(9):1381-6.
    View in: PubMed
    Score: 0.054
  143. Scornik JC, Guerra G, Schold JD, Srinivas TR, Dragun D, Meier-Kriesche HU. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am J Transplant. 2007 Jul; 7(7):1808-14.
    View in: PubMed
    Score: 0.047
  144. Srinivas TR, Schold JD, Guerra G, Eagan A, Bucci CM, Meier-Kriesche HU. Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Am J Transplant. 2007 Mar; 7(3):586-94.
    View in: PubMed
    Score: 0.046
  145. Lansang MC, Ma L, Schold JD, Meier-Kriesche HU, Kaplan B. The relationship between diabetes and infectious hospitalizations in renal transplant recipients. Diabetes Care. 2006 Jul; 29(7):1659-60.
    View in: PubMed
    Score: 0.044
  146. Srinivas TR, Schold JD, Womer KL, Kaplan B, Howard RJ, Bucci CM, Meier-Kriesche HU. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol. 2006 Mar; 1(2):323-6.
    View in: PubMed
    Score: 0.043
  147. Srinivas TR, Kaplan B, Schold JD, Meier-Kriesche HU. The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplantation. 2005 Oct 15; 80(2 Suppl):S211-20.
    View in: PubMed
    Score: 0.042
  148. Womer KL, Peng R, Patton PR, Murawski MR, Bucci M, Kaleem A, Schold J, Efron PA, Hemming AW, Srinivas TR, Meier-Kriesche HU, Kaplan B, Clare-Salzler MJ. The effects of renal transplantation on peripheral blood dendritic cells. Clin Transplant. 2005 Oct; 19(5):659-67.
    View in: PubMed
    Score: 0.042
  149. Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant. 2005 Sep; 5(9):2273-80.
    View in: PubMed
    Score: 0.042
  150. Womer KL, Peng R, Patton PR, Kaleem A, Bucci M, Murawski MR, Schold J, Efron PA, Hemming AW, Srinivas TR, Meier-Kriesche HU, Kaplan B, Clare-Salzler MJ. The effects of renal transplantation on circulating precursor dendritic cells. Transplant Proc. 2005 Jan-Feb; 37(1):3-6.
    View in: PubMed
    Score: 0.040
  151. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant. 2004 Oct; 4(10):1662-8.
    View in: PubMed
    Score: 0.039
  152. Kaplan B, Schold J, Srinivas T, Womer K, Foley DP, Patton P, Howard R, Meier-Kriesche HU. Effect of sirolimus withdrawal in patients with deteriorating renal function. Am J Transplant. 2004 Oct; 4(10):1709-12.
    View in: PubMed
    Score: 0.039
  153. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004 Aug; 4(8):1289-95.
    View in: PubMed
    Score: 0.039
  154. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004 Mar; 4(3):378-83.
    View in: PubMed
    Score: 0.038
  155. Kaplan B, Schold J, Meier-Kriesche HU. Poor predictive value of serum creatinine for renal allograft loss. Am J Transplant. 2003 Dec; 3(12):1560-5.
    View in: PubMed
    Score: 0.037
  156. Kaplan B, Schold JD, Meier-Kriesche HU. Long-term graft survival with neoral and tacrolimus: a paired kidney analysis. J Am Soc Nephrol. 2003 Nov; 14(11):2980-4.
    View in: PubMed
    Score: 0.037
  157. Kaplan B, Schold J, Meier-Kriesche HU. Overview of large database analysis in renal transplantation. Am J Transplant. 2003 Sep; 3(9):1052-6.
    View in: PubMed
    Score: 0.036
  158. Uffing A, P?rez-Sa?z MJ, Jouve T, Bugnazet M, Malvezzi P, Muhsin SA, Lafargue MC, Reindl-Schwaighofer R, Morlock A, Oberbauer R, Buxeda A, Burballa C, Pascual J, von Moos S, Seeger H, La Manna G, Comai G, Bini C, Russo LS, Farouk S, Nissaisorakarn P, Patel H, Agrawal N, Mastroianni-Kirsztajn G, Mansur J, Tedesco-Silva H, Ventura CG, Agena F, David-Neto E, Akalin E, Alani O, Mazzali M, Manfro RC, Bauer AC, Wang AX, Cheng XS, Schold JD, Berger SP, Cravedi P, Riella LV. Recurrence of IgA Nephropathy after Kidney Transplantation in Adults. Clin J Am Soc Nephrol. 2021 08; 16(8):1247-1255.
    View in: PubMed
    Score: 0.031
  159. Meier-Kriesche HU, Schold JD, Gaston RS, Wadstrom J, Kaplan B. Kidneys from deceased donors: maximizing the value of a scarce resource. Am J Transplant. 2005 Jul; 5(7):1725-30.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)